- About Us
- Our Research
- Our People
- Our Facilities
Qatar Biomedical Research Institute (QBRI) is a pioneering national research institute within Hamad bin Khalifa University (HBKU) that aims to improve and transform healthcare through innovation in prevention, diagnosis, and treatment of diseases affecting the Qatari population and the region.
We are at the forefront of the development of advanced national facilities, cutting-edge technologies, and enabling platforms as new scientific discoveries are translated into better therapies and strategies, to combat diseases. As a disease-focused institute we concentrate on applying integrative and multidisciplinary approaches to provide novel insights into the molecular basis of the health challenges of breast cancer; type 2 diabetes; neurological disorders such as dementia and autism; and the development of novel biomarkers, diagnostic and therapeutic strategies. Our aim is to facilitate early diagnosis, treatment, and management of these devastating diseases towards improving personalized medicine and healthcare.
In keeping with Qatar National Health priorities and Qatar National Research Strategy, we operate three scientific centers of excellence:
Our flexible structure allows us to respond to the rapidly changing medical, biomedical, and health needs of Qatari society and industry. This enables rapid adjustment to new scientific and technological advances, which in turn empowers us to remain at the forefront of biomedical research.
We are committed to the training and development of the next generation of scientists and highly skilled workers by providing mentoring, advanced scientific and research training opportunities, and career guidance to young scientists.
QBRI is currently looking to recruit highly-skilled individuals for a number of roles.
Inger van Steenoven, Nour K. Majbour, Nishant Vaikath, Henk W. Berendse, Wiesje M. van der Flier, Wilma D.J. van de Berg, Charlotte E. Teunissen, Afina W. Lemstra, and Omar M.A. El-Agnaf
Journal: Movement Disorders. Article DOI: 10.1002/mds.111, Article ID: MDS111, Internal Article ID: 15859369
Caroline Spasojevic, Elisabetta Marangoni, Sophie Vacher, Franck Assayag, Didier Meseure, Sophie Château-Joubert, Martine Humbert, Manale Karam, Jean Marc Ricort, Christian Auclair, Marie Regairaz and Ivan Bièche (2018).
Oncotarget. Doi: 10.18632/oncotarget.25292
Ali Abouelghar, Reem Hasnah, Ghina Taouk, Mohamad Saad and Manale Karam (2018).
QTV's Hayatuna airs news on QBRI's recent partnership with the Harvard Stem Cell Institute and how this collaboration holds the potential to translate discoveries into clinical applications, while ...
The New partnership will boost region’s first cell-therapy program to tackle diabetes DOHA, October 1, 2018: The Qatar Biomedical Research Institute (QBRI), a premier research institute under Hamad...
Outreach at the Mall to Mark World Alzheimer's Day Under the banner, "Memories Matter", QBRI marked the World Alzheimer's month in September with a series of outreach programs and activities. ...
In light of its mission towards capacity building within the field of Autism Spectrum Disorder (ASD) service provision, Qatar Biomedical Research Institute (QBRI) – a research institute within Hamad...
Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), today signed a memorandum of understanding (MoU) with the Shafallah Center, a non-profit center dedicated to ...